Compare AMBQ & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBQ | OMDA |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | 868 |
| Industry | Semiconductors | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 594.9M | 711.1M |
| IPO Year | N/A | N/A |
| Metric | AMBQ | OMDA |
|---|---|---|
| Price | $34.88 | $14.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $41.75 | $21.73 |
| AVG Volume (30 Days) | 304.4K | ★ 808.6K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $41.81 | $24.94 |
| Revenue Next Year | $27.98 | $20.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.12 | $10.28 |
| 52 Week High | $43.06 | $26.92 |
| Indicator | AMBQ | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 73.02 | 60.15 |
| Support Level | $34.50 | $11.20 |
| Resistance Level | $34.82 | $16.93 |
| Average True Range (ATR) | 1.58 | 0.70 |
| MACD | 0.94 | 0.22 |
| Stochastic Oscillator | 91.40 | 92.27 |
Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute - especially at the edge.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.